Mitochondrial Diseases Part II: Mouse Models of OXPHOS Deficiencies Caused by Defects in Regulatory Factors and Other Components Required for Mitochondrial Function

Overview

Journal Mitochondrion

Specialty Cell Biology

Date 2015 Feb 3

PMID 25640959

Citations 14

Authors

Luisa Iommarini

Susana Peralta

Alessandra Torraco

Francisca Diaz

Affiliations

Soon will be listed here.

Abstract

Mitochondrial disorders are defined as defects that affect the oxidative phosphorylation system (OXPHOS). They are characterized by a heterogeneous array of clinical presentations due in part to a wide variety of factors required for proper function of the components of the OXPHOS system. There is no cure for these disorders owing to our poor knowledge of the pathogenic mechanisms of disease. To understand the mechanisms of human disease numerous mouse models have been developed in recent years. Here we summarize the features of several mouse models of mitochondrial diseases directly related to those factors affecting mtDNA maintenance, replication, transcription, translation as well as other proteins that are involved in mitochondrial dynamics and quality control which affect mitochondrial OXPHOS function without being intrinsic components of the system. We discuss how these models have contributed to our understanding of mitochondrial diseases and their pathogenic mechanisms.

Citing Articles

Mitochondrial DNA maintenance defects: potential therapeutic strategies.

Almannai M, El-Hattab A, Azamian M, Ali M, Scaglia F Mol Genet Metab. 2022; 137(1-2):40-48.

PMID: 35914366 PMC: 10401187. DOI: 10.1016/j.ymgme.2022.07.003.

Enhanced glycolysis and GSK3 inactivation promote brain metabolic adaptations following neuronal mitochondrial stress.

Garcia S, Saldana-Caboverde A, Anwar M, Raval A, Nissanka N, Pinto M Hum Mol Genet. 2021; 31(5):692-704.

PMID: 34559217 PMC: 9077416. DOI: 10.1093/hmg/ddab282.

Advances in mt-tRNA Mutation-Caused Mitochondrial Disease Modeling: Patients' Brain in a Dish.

Povea-Cabello S, Villanueva-Paz M, Suarez-Rivero J, Alvarez-Cordoba M, Villalon-Garcia I, Talaveron-Rey M Front Genet. 2021; 11:610764.

PMID: 33510772 PMC: 7835939. DOI: 10.3389/fgene.2020.610764.

ATAD3 controls mitochondrial cristae structure in mouse muscle, influencing mtDNA replication and cholesterol levels.

Peralta S, Goffart S, Williams S, Diaz F, Garcia S, Nissanka N J Cell Sci. 2018; 131(13).

PMID: 29898916 PMC: 6051345. DOI: 10.1242/jcs.217075.

A disease-associated Aifm1 variant induces severe myopathy in knockin mice.

Wischhof L, Gioran A, Sonntag-Bensch D, Piazzesi A, Stork M, Nicotera P Mol Metab. 2018; 13:10-23.

PMID: 29780003 PMC: 6026322. DOI: 10.1016/j.molmet.2018.05.002.

References

Di Meo I, Fagiolari G, Prelle A, Viscomi C, Zeviani M, Tiranti V . Chronic exposure to sulfide causes accelerated degradation of cytochrome c oxidase in ethylmalonic encephalopathy. Antioxid Redox Signal. 2010; 15(2):353-62. DOI: 10.1089/ars.2010.3520. View

Spinazzola A . Mitochondrial DNA mutations and depletion in pediatric medicine. Semin Fetal Neonatal Med. 2011; 16(4):190-6. DOI: 10.1016/j.siny.2011.04.011. View

Pickrell A, Fukui H, Wang X, Pinto M, Moraes C . The striatum is highly susceptible to mitochondrial oxidative phosphorylation dysfunctions. J Neurosci. 2011; 31(27):9895-904. PMC: 3175592. DOI: 10.1523/JNEUROSCI.6223-10.2011. View

Young M, Longley M, Li F, Kasiviswanathan R, Wong L, Copeland W . Biochemical analysis of human POLG2 variants associated with mitochondrial disease. Hum Mol Genet. 2011; 20(15):3052-66. PMC: 3131046. DOI: 10.1093/hmg/ddr209. View

Kong Y, Van Bergen N, Trounce I, Bui B, Chrysostomou V, Waugh H . Increase in mitochondrial DNA mutations impairs retinal function and renders the retina vulnerable to injury. Aging Cell. 2011; 10(4):572-83. DOI: 10.1111/j.1474-9726.2011.00690.x. View

Linder T, Park C, Asin-Cayuela J, Pellegrini M, Larsson N, Falkenberg M . A family of putative transcription termination factors shared amongst metazoans and plants. Curr Genet. 2005; 48(4):265-9. DOI: 10.1007/s00294-005-0022-5. View

Joza N, Oudit G, Brown D, Benit P, Kassiri Z, Vahsen N . Muscle-specific loss of apoptosis-inducing factor leads to mitochondrial dysfunction, skeletal muscle atrophy, and dilated cardiomyopathy. Mol Cell Biol. 2005; 25(23):10261-72. PMC: 1291246. DOI: 10.1128/MCB.25.23.10261-10272.2005. View

Yin H, Stahl J, Andrade F, McMullen C, Webb-Wood S, Newman N . Eliminating the Ant1 isoform produces a mouse with CPEO pathology but normal ocular motility. Invest Ophthalmol Vis Sci. 2005; 46(12):4555-62. DOI: 10.1167/iovs.05-0695. View

Meyer zum Gottesberge A, Felix H . Abnormal basement membrane in the inner ear and the kidney of the Mpv17-/- mouse strain: ultrastructural and immunohistochemical investigations. Histochem Cell Biol. 2005; 124(6):507-16. DOI: 10.1007/s00418-005-0027-7. View

10.

Tyynismaa H, Mjosund K, Wanrooij S, Lappalainen I, Ylikallio E, Jalanko A . Mutant mitochondrial helicase Twinkle causes multiple mtDNA deletions and a late-onset mitochondrial disease in mice. Proc Natl Acad Sci U S A. 2005; 102(49):17687-92. PMC: 1308896. DOI: 10.1073/pnas.0505551102. View

11.

Trifunovic A, Hansson A, Wredenberg A, Rovio A, Dufour E, Khvorostov I . Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production. Proc Natl Acad Sci U S A. 2005; 102(50):17993-8. PMC: 1312403. DOI: 10.1073/pnas.0508886102. View

12.

Spinazzola A, Viscomi C, Fernandez-Vizarra E, Carrara F, dAdamo P, Calvo S . MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat Genet. 2006; 38(5):570-5. DOI: 10.1038/ng1765. View

13.

Hakonen A, Isohanni P, Paetau A, Herva R, Suomalainen A, Lonnqvist T . Recessive Twinkle mutations in early onset encephalopathy with mtDNA depletion. Brain. 2007; 130(Pt 11):3032-40. DOI: 10.1093/brain/awm242. View

14.

Martelli A, Wattenhofer-Donze M, Schmucker S, Bouvet S, Reutenauer L, Puccio H . Frataxin is essential for extramitochondrial Fe-S cluster proteins in mammalian tissues. Hum Mol Genet. 2007; 16(22):2651-8. DOI: 10.1093/hmg/ddm163. View

15.

Pospisilik J, Knauf C, Joza N, Benit P, Orthofer M, Cani P . Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell. 2007; 131(3):476-91. DOI: 10.1016/j.cell.2007.08.047. View

16.

Sarzi E, Goffart S, Serre V, Chretien D, Slama A, Munnich A . Twinkle helicase (PEO1) gene mutation causes mitochondrial DNA depletion. Ann Neurol. 2007; 62(6):579-87. DOI: 10.1002/ana.21207. View

17.

Detmer S, Vande Velde C, Cleveland D, Chan D . Hindlimb gait defects due to motor axon loss and reduced distal muscles in a transgenic mouse model of Charcot-Marie-Tooth type 2A. Hum Mol Genet. 2007; 17(3):367-75. DOI: 10.1093/hmg/ddm314. View

18.

Hudson G, Amati-Bonneau P, Blakely E, Stewart J, He L, Schaefer A . Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain. 2007; 131(Pt 2):329-37. DOI: 10.1093/brain/awm272. View

19.

Amati-Bonneau P, Valentino M, Reynier P, Gallardo M, Bornstein B, Boissiere A . OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes. Brain. 2007; 131(Pt 2):338-51. DOI: 10.1093/brain/awm298. View

20.

He B, Feng Q, Mukherjee A, Lonard D, DeMayo F, Katzenellenbogen B . A repressive role for prohibitin in estrogen signaling. Mol Endocrinol. 2007; 22(2):344-60. PMC: 2234581. DOI: 10.1210/me.2007-0400. View